Statistics for Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
Total visits
| views | |
|---|---|
| Elacestrant: a new FDA-approved SERD for the treatment of breast cancer | 5 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 1 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 2 |
| March 2026 | 2 |